Found: 257
Select item for more details and to access through your institution.
Innovations in online assessment of suicidality in patients with cancer: Optimizing safety and feasibility.
- Published in:
- 2020
- By:
- Publication type:
- letter
Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transfer of Respiratory Syncytial Virus Prefusion F Protein Antibody in Low Birthweight Infants.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae314
- By:
- Publication type:
- Article
A qualitative exploration of harm reduction in practice by street-based peer outreach workers.
- Published in:
- Harm Reduction Journal, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12954-024-01076-w
- By:
- Publication type:
- Article
Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancer.
- Published in:
- Pilot & Feasibility Studies, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40814-022-01134-9
- By:
- Publication type:
- Article
Qualitative Analysis of Partnerships’ Effect on Implementation of a Nationally Led Community-Based Initiative.
- Published in:
- Health Promotion Practice, 2018, v. 19, n. 5, p. 775, doi. 10.1177/1524839918779378
- By:
- Publication type:
- Article
mRNA vaccines against SARSCoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1020844
- By:
- Publication type:
- Article
Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36001-5
- By:
- Publication type:
- Article
Communicable Disease Outbreaks in Michigan Child Care Centers Compared With State and Regional Epidemics, 2014–2017.
- Published in:
- American Journal of Public Health, 2019, v. 109, n. 12, p. 1707, doi. 10.2105/AJPH.2019.305355
- By:
- Publication type:
- Article
Electroconvulsive therapy in a tertiary Australian mental health facility between 2009 and 2020.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2024, v. 58, n. 8, p. 713, doi. 10.1177/00048674241256839
- By:
- Publication type:
- Article
Landscape heterogeneity rather than crop diversity mediates bird diversity in agricultural landscapes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0200438
- By:
- Publication type:
- Article
Estimands for overall survival in clinical trials with treatment switching in oncology.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 150, doi. 10.1002/pst.2158
- By:
- Publication type:
- Article
Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 493, doi. 10.1093/cid/ciad737
- By:
- Publication type:
- Article
State-of-the-Art Review: Use of Antimicrobials at the End of Life.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. e27, doi. 10.1093/cid/ciad735
- By:
- Publication type:
- Article
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 1980, doi. 10.1093/cid/ciad031
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 8, p. 1358, doi. 10.1093/cid/ciac941
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 6, p. 1030, doi. 10.1093/cid/ciac869
- By:
- Publication type:
- Article
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S271, doi. 10.1093/cid/ciac472
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015–2016 to 2017–2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 8, p. 1329, doi. 10.1093/cid/ciab654
- By:
- Publication type:
- Article
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 12, p. 2240, doi. 10.1093/cid/ciab123
- By:
- Publication type:
- Article
Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4353, doi. 10.1093/cid/ciaa1927
- By:
- Publication type:
- Article
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States—2019–2020.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4244, doi. 10.1093/cid/ciaa1884
- By:
- Publication type:
- Article
Role of Human Bocavirus Respiratory Tract Infection in Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4392, doi. 10.1093/cid/ciaa1149
- By:
- Publication type:
- Article
Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. 1248, doi. 10.1093/cid/ciab395
- By:
- Publication type:
- Article
Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015–2016 to 2018–2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 726, doi. 10.1093/cid/ciab045
- By:
- Publication type:
- Article
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 497, doi. 10.1093/cid/ciaa706
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 386, doi. 10.1093/cid/ciaa407
- By:
- Publication type:
- Article
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 2, p. e445, doi. 10.1093/cid/ciaa954
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance in Decedents in a Large, Urban Medical Examiner's Office.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. e580, doi. 10.1093/cid/ciaa1312
- By:
- Publication type:
- Article
Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. e426, doi. 10.1093/cid/ciaa1023
- By:
- Publication type:
- Article
Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 7, p. 1147, doi. 10.1093/cid/ciaa102
- By:
- Publication type:
- Article
Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 6, p. 995, doi. 10.1093/cid/ciaa160
- By:
- Publication type:
- Article
Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 12, p. 3033, doi. 10.1093/cid/ciz1187
- By:
- Publication type:
- Article
Reducing Antibiotic Use in Ambulatory Care Through Influenza Vaccination.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 11, p. e726, doi. 10.1093/cid/ciaa464
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel: 2015–2016, 2016–2017, and 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2153, doi. 10.1093/cid/ciz125
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 11, p. 1798, doi. 10.1093/cid/ciy775
- By:
- Publication type:
- Article
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 10, p. 1492, doi. 10.1093/cid/cix1040
- By:
- Publication type:
- Article
A Comparison of Parathyroid Hormone-Related Protein (1-36) and Parathyroid Hormone (1-34) on Markers of Bone Turnover and Bone Density in Postmenopausal Women: The PrOP Study.
- Published in:
- Journal of Bone & Mineral Research, 2014, v. 29, n. 3, p. 770, doi. 10.1002/jbmr.2149
- By:
- Publication type:
- Article
A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: The PrOP study.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 11, p. 2266, doi. 10.1002/jbmr.1978
- By:
- Publication type:
- Article
Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 45, doi. 10.1093/infdis/jiae090
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccine Strain Selection: Guidance from Influenza.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 4, doi. 10.1093/infdis/jiac454
- By:
- Publication type:
- Article
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor (BTKI) Evobrutinib in Relapsing Multiple Sclerosis over 108 Weeks: Open-Label Extension to a Phase 2 Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 87
- By:
- Publication type:
- Article
(DXT36) Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, on Immune Cell and Immunoglobulin Levels over 48 Weeks in a Phase 2 Study in Relapsing Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 28
- By:
- Publication type:
- Article